Legislation aims to prevent teen abuse of cough medicine

Reprints

​Washington – Sens. Bob Casey Jr. (D-PA) and Lisa Murkowski (R-AK) recently introduced legislation aimed at preventing teen abuse of over-the-counter cough medicine.

The Preventing Abuse of Cough Treatments Act (S. 644) would amend the Federal Food, Drug, and Cosmetic Act to prohibit the sale of OTC cough medicines containing dextromethorphan – which can produce hallucinogenic effects at higher doses – to anyone younger than 18 (unless presenting a prescription). Recreational use of DXM is sometimes called “robotripping” or “skittling.” 

According to a press release from Casey’s office, approximately 5 percent of teenagers have purposefully taken large amounts of DXM, which also can cause confusion, blurred vision and loss of motor control. 

Post a comment to this article

Safety+Health welcomes comments that promote respectful dialogue. Please stay on topic. Comments that contain personal attacks, profanity or abusive language – or those aggressively promoting products or services – will be removed. We reserve the right to determine which comments violate our comment policy. (Anonymous comments are welcome; merely skip the “name” field in the comment box. An email address is required but will not be included with your comment.)